Fostering the development of AI-enhanced technologies to support healthy aging in place of choice for older adults and individuals with Alzheimer’s disease.
An AI-powered Digital Therapy Assistant for Monitoring and Treating Cognitive Impairment
Investigators:
Jennifer Flexman, Moneta Health
Michael Busa, UMass Amherst
Voiceitt: AI-Enabled Speech Recognition for Older Adults with Severe Dysarthria
Investigators:
Katie Seaver, The Babel Group
Rachel Levy, The Babel Group
Using AI to Repurpose Small Molecules to Target Amyloid-tau Interactions in AD
Investigators:
Jeremy Linsley, Operant BioPharma
